Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 91 AL 105

The microbiota-proteostasis axis: implications in neurodegenerative diseases

Czyż DM, Brown BM.

Philos Trans R Soc Lond B Biol Sci. 2026 Oct 1;381(1960):20250265. doi: 10.1098/rstb.2025.0265.

Potential of Ginkgo biloba Extract to Intervene in Chronic Inflammation-Related Diseases

Lin Y, Cho I, Zhu X, Wang K, Zhu L, Wong W, Murray M, Zhou F.

Phytother Res. 2026 Oct 1. doi: 10.1002/ptr.70467. Online ahead of print.

The close relationship between a rare disease and a common disease: Case report of a patient with gaucher disease and parkinsonism

Oliveira JLG, Montenegro MVB, Fontoura NM, Trindade SMS, Reis APB, de Freitas RIR, Dos Santos Silva AM, Dos Santos Lobato BL, Santana-da-Silva LC.

Neurol Sci. 2026 Oct 1;47(10):827. doi: 10.1007/s10072-026-09427-0.

The Fabulous Game of Parkinson Disease Biomarkers

Fabiani G, Amarante DF.

Neurology. 2026 Oct 27;107(8):e218639. doi: 10.1212/WNL.0000000000218639. Epub 2026 Oct 1.

Oscillopathic features and neuromodulation with tACS in people with Parkinson's disease: A semi-systematic review

Opie GM.

Neurosci Biobehav Rev. 2026 Dec;191:107006. doi: 10.1016/j.neubiorev.2026.107006. Epub 2026 Oct 2.

Short-term efficacy and safety of tavapadon for Parkinson's disease: An exploratory systematic review and meta-analysis of randomized clinical trials

Campos TS, Pereira PS, Pires Marques ME, de Sousa Fernandes LR, Grassi Simões PR, Ribeiro TC, de Oliveira MPR, Andrade Nascimento Almeida M, Gonçalves OR, Nery GG, Andrade PGG.

Parkinsonism Relat Disord. 2026 Nov;152:108995. doi: 10.1016/j.parkreldis.2026.108995. Epub 2026 Sep 27.

The good, the bad, and the ugly: A three-circuit model of Parkinson's tremor

Helmich RC, van den Berg KRE.

Rev Neurol (Paris). 2026 Nov;182(9):806-810. doi: 10.1016/j.neurol.2026.09.003. Epub 2026 Oct 1.

In vivo detection of pathologic α- synuclein and TDP-43 in the skin and olfactory mucosa of a patient with Parkinson's disease-like phenotype carrying the p.Thr272Serfs*10 GRN mutation

Caroppo P, Aprea V, Villa C, Dellarole IL, Romeo A, Rossi G, Ciullini A, Burato A, Prioni S, Grisoli M, Legname G, Simmini G, Luppino A, Mazzetti S, Moda F, Devigili G.

Mol Neurodegener. 2026 Oct 1;21(1):61. doi: 10.1186/s13024-026-01000-9.

Outcomes of a Simplified Two-Catheter Approach for Catheter Ablation of SVT in Pediatric Patients

Cervantes JD, Mansour AA, Cortez D.

Pacing Clin Electrophysiol. 2026 Oct 2. doi: 10.1111/pace.70458. Online ahead of print.

AI-driven transcriptomics for neurodegenerative disease research: A systematic review

Tripathi A, Yadav AK, Kumar N.

Comput Biol Chem. 2026 Sep 29;126(Pt 1):109448. doi: 10.1016/j.compbiolchem.2026.109448. Online ahead of print.

Dopaminergic transmissive dormancy as a protective state against cellular stress

Zuurbier KR, Solano Fonseca R, Snowden J, Douglas PM.

Genes Dev. 2026 Oct 2. doi: 10.1101/gad.353957.126. Online ahead of print.

Beyond granulomatous amoebic encephalitis: changing epidemiology and an expanding spectrum of non-flagellated amoebic CNS infection in India

Gupta N, Reghukumar A, Kumar TP.

Infection. 2026 Oct 3. doi: 10.1007/s15010-026-02986-6. Online ahead of print.

Precision cognitive neurorehabilitation: dose, adaptivity, digital therapeutics and implementation

Sander FW, Sallard É, Silva M, Schneider L, Diserens K, Graf C, Serino A, Sokolov AA.

Expert Rev Neurother. 2026 Nov;26(11):1123-1140. doi: 10.1080/14737175.2026.2723909. Epub 2026 Oct 4.

From danger to resolution: targeting purinergic signaling in CNS diseases

Degryse C, Gupta K, Buée L, Burnouf T, Blum D, Chou ML.

Med Chem Res. 2026 Oct;35(10):2007-2027. doi: 10.1007/s00044-026-03583-w. Epub 2026 Oct 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias